Artificial urinary sphincters
€23M Series B extension from
← All transactions
UroMems: €12M Series B from Supernova Invest, Bpifrance, b2venture, Wellington Partners, CITA
Exclusive advisor to the company
- Date
- Nov 2016
- Sector
- Healthcare
- Business
- Urology
- Transaction
- €12M Series B from Supernova Invest, Bpifrance, b2venture, Wellington Partners, CITA
- Apparius’s role
- Exclusive advisor to the company
- Area of focus
- Medical devices
After a proof of concept backed by BizMedTech and business angels, UroMems raised €12 million from a pool of European investors to develop its active implantable device for urinary incontinence, a market with no real innovation since the 1970s.
Other transactions with UroMems
Artificial urinary sphincters
€12.5M Series B from
